LA HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Diabetes drug developer MannKind Corp. of Valencia is exploring multiple partnership opportunities to take its inhalable insulin drug Afrezza to market as the company awaits FDA approval.
Amgen Inc. appointed David W. Meline as its chief financial officer on Monday, luring him from 3M with a $2 million signing bonus.
Shares of Westwood drug developer Puma Biotechnology plummeted in trading on Monday after presentations by the company and another drugmaker soured investors on their prospects.
Samsung Group, the largest company in South Korea, plans to enter the drug trade by competing directly with Amgen Inc. in Thousand Oaks.
MannKind Inc. reported a smaller loss for the first quarter on Monday as it awaits government approval to sell its brand of inhalable insulin.
IPC The Hospitalist Co. Inc. is acquiring Total Inpatient Services in Sugar Land, Texas.
J2 Global Inc. on Thursday reported a 26 percent rise in first-quarter net income, as the Hollywood provider of media services saw increasing strength in its cloud data backup services business. Marcus & Millichap Inc. reported soaring revenue the quarter, citing the continued recovery of the commercial real estate market. Apollo Medical Holdings Inc. reported a narrower loss and higher revenue in its last fiscal year, crediting a string of recent acquisitions and expansions.
Shares jumped Wednesday for Health Net, Live Nation Entertainment, and Activision Blizzard after the companies reported better-than-expected first quarter results. PennyMac Mortgage Investment Trust struggled, but affiliate PennyMac Financial Services met analyst expectations.
Superior Industries International Inc. matched analysts’ net income estimates for the first quarter but just missed on revenue. Crown Media Holdings Inc. reported a drop in net income for the first quarter despite rising ratings and advertising rates. Molina Healthcare reported a profit for the quarter when analyst were expecting a loss.
NantHealth, billionaire Patrick Soon-Shiong’s health care technology company, on Tuesday announced it is getting an investment of $100 million from Kuwait’s sovereign wealth fund.
Herbalife Ltd. reported a 37 percent drop in first-quarter profit Monday and said it would suspend its quarterly dividend so it could use the cash to repurchase shares. Adjusted net income and sales were better than expected.
A slimmer Avery Dennison Corp. on Wednesday announced fiscal first quarter results that were in line with Wall Street expectations for profit. Cheesecake Factory Inc. said Wednesday that same-store sales rose at most of its outlets during the fiscal first quarter but poor weather cut into profits. IPC disappoints. Defense cuts hit Teledyne. On Assignment meets forecasts.
Amgen Inc. on Tuesday reported a lower-than-expected first quarter profit, but said it plans to submit its experimental cholesterol drug for approval by the end of the year.
The U.S. Food and Drug Administration has granted fast-track designation for ivabradine, a heart drug licensed for sale by Amgen Inc. in Thousand Oaks.
The Illinois Attorney General’s Office on Thursday said that it is investigating allegations that Herbalife is running a pyramid scheme.